Page 186 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 186

172     SECTION II  Autonomic Drugs


                 Fitzgerald JD: Do partial agonist beta-blockers have improved clinical utility?   Nickerson M:  The pharmacology of adrenergic blockade. Pharmacol Rev
                    Cardiovasc Drugs Ther 1993;7:303.                    1949;1:27.
                 Freemantle N et al: Beta blockade after myocardial infarction: Systematic review   Okamoto LE et al: Nebivolol, but not metoprolol lowers blood pressure in nitric
                    and meta regression analysis. BMJ 1999;318:1730.     oxide-sensitive human hypertension. Hypertension 2014;64:1241.
                 Hogeling M, Adams S, Wargon O: A randomized controlled trial of propranolol   Perez DM: Structure-function of alpha1-adrenergic receptors. Biochem Pharmacol
                    for infantile hemangiomas. Pediatrics 2011;128:e259.  2007;73:1051.
                 Jacobs DS: Open-angle glaucoma: Treatment. UpToDate.com 2013, topic 15695.  Pojoga L et al: Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive
                 Kamp O et  al: Nebivolol:  Haemodynamic effects and  clinical  significance of     hypertension. Hypertension 2006;48:892.
                    combined β-blockade and nitric oxide release. Drugs 2010;70:41.  Raj SR et al: Propranolol decreases tachycardia and improves symptoms in the
                 Kaplan SA et al: Combination therapy using oral β-blockers and intracavernosal   postural tachycardia syndrome: Less is more. Circulation 2009;120:725.
                    injection in men with erectile dysfunction. Urology 1998;52:739.  Robertson D et al: Primer on the Autonomic Nervous System, 3rd ed. Cambridge,
                 Kyprianou N: Doxazosin and terazosin suppress prostate growth by inducing   MA: Academic Press, 2012.
                    apoptosis: Clinical significance. J Urol 2003;169:1520.  Roehrborn CG, Schwinn DA: Alpha1-adrenergic receptors and their inhibitors
                 Lanfear DE et al: β2-Adrenergic receptor genotype and survival among patients   in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol
                    receiving  β-blocker therapy after an acute coronary syndrome. JAMA   2004;171:1029.
                    2005;294:1526.                                   Schwinn DA, Roehrborn CG: Alpha1-adrenoceptor subtypes and lower urinary
                 Lepor H et al: The efficacy of terazosin, finasteride, or both in benign prostate   tract symptoms. Int J Urol 2008;15:193.
                    hyperplasia. N Engl J Med 1996;335:533.          Shibao C et al: Comparative efficacy of yohimbine against pyridostigmine for the
                 Maggio PM, Taheri PA: Perioperative issues: Myocardial ischemia and protection–  treatment of orthostatic hypotension in autonomic failure. Hypertension
                    beta-blockade. Surg Clin North Am 2005;85:1091.      2010;56:847.
                 McVary KT: Alfuzosin for symptomatic benign prostatic hyperplasia: Long-term   Tank J et al: Yohimbine attenuates baroreflex-mediated bradycardia in humans.
                    experience. J Urol 2006;175:35.                      Hypertension 2007;50:899.
                 Nickel JC, Sander S, Moon TD: A meta-analysis of the vascular-related safety     Wilt TJ,  MacDonald  R,  Rutks  I: Tamsulosin  for  benign  prostatic  hyperplasia.
                    profile and  efficacy of  alpha-adrenergic  blockers for symptoms related  to   Cochrane Database Syst Rev 2003;1:CD002081.
                    benign prostatic hyperplasia. Int J Clin Pract 2008;62:1547.



                   C ASE  STUD Y  ANSWER

                   The patient had a pheochromocytoma. This tumor secretes cat-  rate increase, producing a typical episode during the examina-
                   echolamines, especially norepinephrine and epinephrine, result-  tion, perhaps set off in this case by external pressure as the phy-
                   ing in increases in blood pressure (via α  receptors) and heart   sician palpated the abdomen. His profuse sweating was typical
                                                 1
                   rate (via β  receptors). The pheochromocytoma was in the left   and partly due to α  receptors, although the large magnitude of
                                                                                    1
                           1
                   adrenal gland and was identified by meta-iodobenzylguanidine   drenching sweats in pheochromocytoma has never been fully
                   (MIBG) imaging, which labels tissues that have norepinephrine   explained. Treatment would consist of preoperative pharma-
                   transporters on their cell surface (see text). In addition, he had   cologic control of blood pressure and normalization of blood
                   elevated plasma and urinary norepinephrine, epinephrine, and   volume if reduced, followed by surgical resection of the tumor.
                   their metabolites, normetanephrine and metanephrine. The   Control of blood pressure extremes might be necessary during
                   catecholamines made the blood pressure surge and the heart   surgery, probably with nitroprusside.
   181   182   183   184   185   186   187   188   189   190   191